Non-aspirin NSAIDs linked with 30-60% reduced risk of Alzheimer's in early study results.
This article was originally published in The Tan Sheet
NON-ASPIRIN NSAIDs LINKED TO 30-60% REDUCED RISK OF ALZHEIMER'S DISEASE in preliminary results of a Johns Hopkins University longitudinal study presented at the American Academy of Neurology annual meeting in San Francisco on March 28. In the study, acetaminophen and aspirin provided "no significant protection" against the illness, according to study presenters.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC